Diimidazo[1,2-c:4',5'-e]pyrimidines: adenosine agonist activity demonstrated by microphysiometry

Area of Science:

• Biochemistry and pharmacology
• Cell biology

Background:

• Adenosine A1 receptor is a key target in various physiological processes.
• Diimidazo[1,2-c:4',5'-e]pyrimidine derivatives represent a novel class of compounds with potential biological activity.

Purpose of the Study:

• To investigate the potential of diimidazo[1,2-c:4',5'-e]pyrimidine derivatives as agonists at the human adenosine A1 receptor.
• To characterize the activity of these compounds using cell-based assays.

Main Methods:

• Silicon-based microphysiometry was employed to measure the extracellular acidification rate of cultured cells.
• This technique allowed for real-time monitoring of cellular responses to compound stimulation.

Main Results:

• A series of diimidazo[1,2-c:4',5'-e]pyrimidines were identified as agonists of the human adenosine A1 receptor.
• Compound 2a, specifically 5-amino-7,8-dihydro-3-ribofuranose-8-(R)-(phenyl)-3H-diimidazo [1,2-c:4',5'-e]pyrimidine, exhibited an EC50 of 100 microM.
• Compound 2a achieved 90% of the maximal effect (Emax) observed with R-PIA, a known adenosine A1 receptor agonist.

Conclusions:

• Diimidazo[1,2-c:4',5'-e]pyrimidine derivatives show promise as modulators of adenosine A1 receptor activity.
• These findings contribute to the development of novel therapeutic agents targeting adenosine A1 receptor-mediated pathways.